Reshape the fates of Treg and CD8+ T cells through IL-2Rα by synergizing divergent receptor-biased IL-2 PEGylates

Journal of Chinese Pharmaceutical Sciences ›› 2025, Vol. 34 ›› Issue (5): 496-496.

• News • Previous Articles Next Articles

Reshape the fates of Treg and CD8+ T cells through IL-2Rα by synergizing divergent receptor-biased IL-2 PEGylates

Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University Health Science Center

Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University Health Science Center

Received:2025-05-10 Revised:2025-05-10 Accepted:2025-05-10 Online:2025-06-02 Published:2025-06-01

Abstract

Supporting:

Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University Health Science Center. Reshape the fates of Treg and CD8+ T cells through IL-2Rα by synergizing divergent receptor-biased IL-2 PEGylates[J]. Journal of Chinese Pharmaceutical Sciences, 2025, 34(5): 496-496.

Reshape the fates of Treg and CD8+ T cells through IL-2Rα by synergizing divergent receptor-biased IL-2 PEGylates

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 0

Recommended Articles

Metrics

Comments